ClinicalTrials.Veeva

Menu

Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds

Dartmouth Health logo

Dartmouth Health

Status and phase

Begins enrollment in 5 months
Phase 4

Conditions

Spinal Disease
Post Operative Pain
Anesthesia

Treatments

Drug: Normal saline
Drug: Lidocaine in Saline

Study type

Interventional

Funder types

Other

Identifiers

NCT06792474
STUDY02002708

Details and patient eligibility

About

The purpose of this study is to determine the effect of lidocaine infusion on intraoperative neuromonitoring in patients undergoing spine surgery.

Full description

The investigators will compare the stimulation threshold for motor evoked potentials (MEPs) for patients undergoing spine surgery with intraoperative neurophysiologic monitoring (IONM) who receive a lidocaine infusion vs. normal saline (NS) infusion. The endpoint for this objective will be the final stimulation threshold for MEPs at the end of the surgery. The stimulation threshold for MEPs is a commonly used metric to determine the effects of anesthetic agents on MEP signals. Secondary objectives will somatosensory evoked potentials (SSEPs) with an endpoint of amplitude and latency of SSEPs throughout the surgery. Other secondary outcomes will include, intraoperative mean arterial pressure (MAP), intraoperative propofol consumptions, and post-operative visual analog scale (VAS) and opioid consumption.

Enrollment

44 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients undergoing elective cervical or thoracolumbar spine surgery with intraoperative neurophysiological monitoring

Exclusion criteria

  • Inability to provide informed consent in English
  • Pregnancy (based on patient report or a positive test on the day of surgery)
  • Contraindication to lidocaine
  • Planned post-operative intubation
  • Current incarceration

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

44 participants in 2 patient groups

Lidocaine Infusion (Active)
Active Comparator group
Description:
Lidocaine infusion
Treatment:
Drug: Lidocaine in Saline
Normal Saline Infusion (Sham)
Sham Comparator group
Description:
Normal saline infusion
Treatment:
Drug: Normal saline

Trial contacts and locations

1

Loading...

Central trial contact

Lauren K Buhl, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems